2/8/2012

Illumina's board rejected Roche's $5.7 billion takeover bid and advised shareholders not to tender their shares to Roche. Illumina said the bid undervalued the gene-sequencing firm. Roche called the offer "full and fair" and said it was ready to enter discussions with Illumina.

Full Story:
Reuters

Related Summaries